Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 4/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17547721 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 | |
| SCHEMBL13926098 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 | |
| SCHEMBL16367585 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 | |
| SCHEMBL13980321 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 | |
| SCHEMBL12116872 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 | |
| SCHEMBL17342342 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 | |
| SCHEMBL13971248 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 | |
| SCHEMBL12359819 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 | |
| SCHEMBL13104087 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 | |
| SCHEMBL2754594 | 1.00 | G6PD (0.57) | G6PDGAACA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11771688-B2 | Pyridine derivatives substituted by heterocyclic ring and amino group | AMPLYX PHARMACEUTICALS, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| WO-2022144369-A1 | FRAGRANCED COSMETIC COMPOSITION COMPRISING AN ORGANIC ACID, A NATURAL ANTHOCYANI(DI)N DYE AND A FRAGRANCING MATERIAL, AND PROCESS FOR TREATING KERATIN MATERIALS AND/OR CLOTHING USING THE COMPOSITION | L'OREAL (FR) | 2022-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11771688-B2 | Pyridine derivatives substituted by heterocyclic ring and amino group | ERG28, PDXK, PAH | G6PD 5/4885GAA 359/4885CA1 4737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.